Focus of our research is to meet patient's need
Beta Drugs limited is amongst a handful of Indian Oncology companies to foresee the importance of R&D and invest heavily in these activities. We have highly accomplished team of dedicated scientists for process and analytical work.
We are extensively working for NDDS like Liposomes, Nanoparticles, or Micro-particulate systems. We are one of the few Indian companies who have successfully developed & commercialized Nanoparticle –Albumin–Bound Paclitaxel, Ready to use Docetaxel & Gemcitabine.
We are extensively working on a New Drug Delivery System (NDDS), PARP Inhibitors & Targeted Therepies (NIB's).
We also have one of the richest product pipeline of targeted therapies which at different stages of development.